isopaque 350 mg
nycomed (uk) limited - i millilitre
isopaque 350 mg
nycomed (uk) limited - i millilitre
isopaque amin 200 mg
nycomed (uk) limited - i millilitre
isopaque amin 200 mg
nycomed (uk) limited - i millilitre
isopaque coronar 370
electramed ireland limited - 20 millilitre
isopaque cysto 100
electramed ireland limited - 50 millilitre
isopaque cysto 100 mg
nycomed (uk) limited - sodium metrizoate calcium metrizoate magnesium metrizoate meglumine metrizoate - i millilitre
visipaque iodixanol 97.8g/150ml (652mg/ml) injection bottle
ge healthcare australia pty ltd - iodixanol, quantity: 652 mg/ml - injection, solution - excipient ingredients: water for injections; sodium calcium edetate; trometamol; calcium chloride dihydrate; sodium hydroxide; sodium chloride; hydrochloric acid - visipaque is indicated, in adult patients, for angiocardiography, peripheral arteriography, visceral arteriography, cerebral arteriography, contrast-enhanced computed tomography of the head and body, excretory urography and venography. in arteriography, visipaque may be used for both conventional radiography and digital subtraction angiography (dsa).
visipaque iodixanol 13.0g/20ml (652mg/ml) injection ampoule
ge healthcare australia pty ltd - iodixanol, quantity: 652 mg/ml - injection, solution - excipient ingredients: water for injections; sodium calcium edetate; trometamol; calcium chloride dihydrate; sodium hydroxide; sodium chloride; hydrochloric acid - this medicinal product is for diagnostic use only. visipaque is indicated in adult patients for angiocardiography, peripheral arteriography, visceral arteriography, cerebral arteriography, contrast-enhanced computed tomography of the head and body, excretory urography and venography. in arteriography, visipaque may be used for both conventional radiography and digital subtraction angiography (dsa). in children, visipaque is indicated for cardioangiography, urography, ct enhancement and studies of the upper gastrointestinal tract.
visipaque iodixanol 11.0g/20ml (550mg/ml) injection vial
ge healthcare australia pty ltd - iodixanol, quantity: 550 mg/ml - injection, solution - excipient ingredients: sodium calcium edetate; calcium chloride dihydrate; trometamol; water for injections; sodium chloride; sodium hydroxide; hydrochloric acid - this medicinal product is for diagnostic use only. visipaque is indicated in adult patients for angiocardiography, peripheral arteriography, visceral arteriography, cerebral arteriography, contrast-enhanced computed tomography of the head and body, excretory urography and venography. in arteriography, visipaque may be used for both conventional radiography and digital subtraction angiography (dsa). in children, visipaque is indicated for cardioangiography, urography, ct enhancement and studies of the upper gastrointestinal tract.